4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-051389
SVP, COO & CFO sold 2,000 shares at $19.96 ($39,920)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP, COO & CFO | 2020-09-17 | Sale | −2,000 | $19.96 | $39,920 | 235,249 | D: show line 1 in the form |
| Open-market sales · 2,000 sh · avg $19.96 · $39,920 | |||||||
Loading xslF345X03/doc4.xml…